This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
92
Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml
Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
RECRUITINGIntraoperative hypotension
MAP \< 80 mmHg
Time frame: During surgery
Inotropic requirements
cumulative doses of inotropics during surgery
Time frame: During surgery
Incidence of bradycardia
heart rate \< 40/min
Time frame: During surgery
Incidence of tachycardia
heart rate \> 100/min
Time frame: During surgery
Maximum systolic blood pressure
maximal systolic blood pressure
Time frame: During surgery
Minimum systolic blood pressure
minimal systolic blood pressure
Time frame: During surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.